Plasma platelet-activating factor acetylhydrolase is a secreted phospholipase A2 with a catalytic triad
about
Identification of essential residues for the catalytic function of 85-kDa cytosolic phospholipase A2. Probing the role of histidine, aspartic acid, cysteine, and argininecDNA cloning and expression of intracellular platelet-activating factor (PAF) acetylhydrolase II. Its homology with plasma PAF acetylhydrolaseThe Ile198Thr and Ala379Val variants of plasmatic PAF-acetylhydrolase impair catalytical activities and are associated with atopy and asthmaPlatelet-activating factor acetylhydrolase deficiency. A missense mutation near the active site of an anti-inflammatory phospholipaseLipoprotein-associated phospholipase A2 prognostic role in atherosclerotic complicationsTo hydrolyze or not to hydrolyze: the dilemma of platelet-activating factor acetylhydrolasePhospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic interventionProbing the substrate specificity of the intracellular brain platelet-activating factor acetylhydrolaseCrystal Structure of Human Plasma Platelet-activating Factor Acetylhydrolase: STRUCTURAL IMPLICATION TO LIPOPROTEIN BINDING AND CATALYSISCrystal structures of human group-VIIA phospholipase A2 inhibited by organophosphorus nerve agents exhibit non-aged complexesChlorophyllase as a serine hydrolase: identification of a putative catalytic triadPhospholipase A2 biochemistryPhospholipases A₁Anti-apoptotic actions of the platelet-activating factor acetylhydrolase I alpha2 catalytic subunitA broader view: microbial enzymes and their relevance in industries, medicine, and beyond.Effect of the leptin receptor Q223R polymorphism on the host transcriptome following infection with Entamoeba histolytica.Phospholipase A2: its usefulness in laboratory diagnostics.Genetic invalidation of Lp-PLA2 as a therapeutic target: Large-scale study of five functional Lp-PLA2-lowering alleles.vLIP, a viral lipase homologue, is a virulence factor of Marek's disease virus.Deficiency of platelet-activating factor acetylhydrolase is a severity factor for asthmaRapid production of platelet-activating factor is induced by protein kinase Cα-mediated phosphorylation of lysophosphatidylcholine acyltransferase 2 proteinPAF acetylhydrolase gene polymorphisms and asthma severity.The emerging roles of PAF acetylhydrolase.Lipoprotein-associated phospholipase A2 is an independent predictor of incident coronary heart disease in an apparently healthy older population: the Rancho Bernardo Study.Crystallization and preliminary X-ray crystallographic analysis of human plasma platelet activating factor acetylhydrolase.cDNA cloning and expression pattern of homolog of alpha subunit of platelet-activating factor acetylhydrolase Ib from the Chinese oak silkworm, Antheraea pernyi.Lipopolysaccharide Cross-Tolerance Delays Platelet-Activating Factor-Induced Sudden Death in Swiss Albino Mice: Involvement of Cyclooxygenase in Cross-ToleranceOxidatively truncated phospholipids are required agents of tumor necrosis factor α (TNFα)-induced apoptosis.PLAC test for identification of individuals at increased risk for coronary heart disease.Modulation of oxidative stress, inflammation, and atherosclerosis by lipoprotein-associated phospholipase A2Determination of phospholipase activity of PAF acetylhydrolaseStructural basis of specific interactions of Lp-PLA2 with HDL revealed by hydrogen deuterium exchange mass spectrometryComprehensive genetic analysis of the platelet activating factor acetylhydrolase (PLA2G7) gene and cardiovascular disease in case-control and family datasets.Hypothesis: hemolytic transfusion reactions represent an alternative type of anaphylaxisPhospholipase A2 structure/function, mechanism, and signaling.Differential expression of platelet-activating factor acetylhydrolase in lung macrophages.Phospholipase A2 inhibitors as potential therapeutic agents for the treatment of inflammatory diseases.Lipid rafts and redox regulation of cellular signaling in cholesterol induced atherosclerosis.Phospholipase A2 inhibitors for the treatment of inflammatory diseases: a patent review (2010--present).Molecular characterization of the constitutive expression of the plasma platelet-activating factor acetylhydrolase gene in macrophages.
P2860
Q24311432-CDEA1EBF-7D25-4D75-A3EC-963E5A425AC0Q24336429-C2F5F14A-13BE-42B8-B35E-5D5BFD0CC7AAQ24540170-FCC850DD-6559-4453-86DC-CCC40AF53FE3Q24562119-4DD18CA8-2386-4613-B173-C8B1ACAE3BB8Q26777871-6C15D301-AB36-4E61-A4F8-F9648409ABF2Q26865969-2FFCAA98-DA15-47D9-B4E2-49177E76F302Q26997377-97587355-6205-45A6-817B-0ED499DA2491Q27619562-0AB93573-5602-4535-BECF-55A1DBB653CFQ27652078-155FC3FD-902B-45D8-931D-68BB40FC9BA8Q27655257-3AB7FCA4-5E3D-40F7-A9B8-068ADC26632EQ28205319-8311B57D-2941-4B37-A410-F5623BEC5543Q28297979-C7CB4B33-992E-4A3B-AF03-7793ECF206AAQ28305868-17C78296-F191-450B-A8AF-7B97BFC9A0B4Q28564311-CCB73E10-1AC2-409A-BDF9-A4A5CF61D0C1Q30393023-924B4319-8654-4124-8579-6D83861E8E35Q30416574-42D29302-4752-45FD-9C6C-98DAD485FA0FQ33702391-A09F92B6-DCC9-40D4-896F-CEC8109C73D0Q33768940-692349C8-8F0B-40CD-812D-CF1ADA21F2C4Q33788825-B6D044A3-73D7-4053-AF05-4CF3FD4FC595Q33848692-F62F600C-7108-431C-AB1D-7C92E5A48D36Q34075985-62F34242-20D4-40B2-A7B8-4EC6D1C6190DQ34355213-5B45E2D0-626A-4592-A926-174C362ED5FEQ34847192-70B9CE4C-382E-4BD7-ACD7-1FD8A374A0FCQ34987055-8E98EDF4-7440-475C-AE6C-BE8995C2E8C5Q35563996-DFC06F9F-7889-4316-AAA7-0C0F24AC31D5Q35762125-515C56F2-A2E0-4302-BD22-344DCDA47610Q35985649-5A2716A9-EE78-49F7-A06E-21D5CD8AC1C1Q36006794-5E7B60A7-0EC8-4DCC-8111-6521D300C88AQ36050527-E33FC01A-FB96-48C8-B95A-74420B94AF68Q36145180-7E231C3A-CFEB-4B06-8DA4-8F74EB35EFFDQ36240691-C1E990EC-8643-4204-A990-57D9C741EE1CQ36462031-C656E877-0FC0-4793-9995-818066046F3FQ37120610-FAC72BB0-A60E-4943-A86A-263A98D71CC8Q37284681-18342A4E-1A7E-4E41-8FE4-F8939CD0D61EQ37326136-21703CD2-D641-46FE-B689-C6B982489FDBQ37475022-D00C6779-6706-4981-8C24-39276B88F8E9Q37658843-4A4D15E0-8218-43B5-8CDF-2DB0E231593CQ37951442-5E11D9D9-5458-4ECC-B073-CE325123D8FCQ38072094-17955284-5E37-4DE1-AC94-C4BA935406AFQ38352665-8D128ED5-FBDF-4448-B01E-1A61CC146B08
P2860
Plasma platelet-activating factor acetylhydrolase is a secreted phospholipase A2 with a catalytic triad
description
1995 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique Journal of Biological Chemistry
@fr
artículu científicu espublizáu en 1995
@ast
im Oktober 1995 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1995/10/27)
@sk
vědecký článek publikovaný v roce 1995
@cs
wetenschappelijk artikel (gepubliceerd op 1995/10/27)
@nl
наукова стаття, опублікована в жовтні 1995
@uk
name
Plasma platelet-activating fac ...... pase A2 with a catalytic triad
@ast
Plasma platelet-activating fac ...... pase A2 with a catalytic triad
@en
Plasma platelet-activating fac ...... pase A2 with a catalytic triad
@nl
type
label
Plasma platelet-activating fac ...... pase A2 with a catalytic triad
@ast
Plasma platelet-activating fac ...... pase A2 with a catalytic triad
@en
Plasma platelet-activating fac ...... pase A2 with a catalytic triad
@nl
prefLabel
Plasma platelet-activating fac ...... pase A2 with a catalytic triad
@ast
Plasma platelet-activating fac ...... pase A2 with a catalytic triad
@en
Plasma platelet-activating fac ...... pase A2 with a catalytic triad
@nl
P2093
P3181
P356
P1476
Plasma platelet-activating fac ...... pase A2 with a catalytic triad
@en
P2093
C. Eberhardt
D. M. Stafforini
G. A. Zimmerman
H. L. Trong
L. W. Tjoelker
P. W. Gray
S. M. Prescott
T. M. McIntyre
P304
25481–25487
P3181
P356
10.1074/JBC.270.43.25481
P407
P577
1995-10-27T00:00:00Z